Arkolith/Insider Trading/TBPH/Form 4

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRSTheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$434K
Net Open-Market Flow
-$434K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)8K$13.92$108K256K
Mar 16, 2026Sell(S)8K$13.92$108K233K
Mar 16, 2026Sell(S)16K$14.00$217K240K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001898490-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML